Research on Phase II detoxification estimates that glutathione conjugation is responsible for detoxifying up to 60% of all therapeutic drugs, environmental toxins, and heavy metals
Guidelines for the diagnosis and treatment of cobalamin and folate disorders
D57 (CTR) and D254 (G), were predicted protonated, however, visual inspection did not support this prediction because of their solvent-exposed location and, therefore, were modelled in the anionic side chain form
Understanding the 503A Bulks List Section 503A of the Federal Food, Drug, and Cosmetic Act sets the conditions that must be met for a compounded drug product to be exempt from three key federal requirements: current good manufacturing practice standards, labeling with adequate directions for use, and approval under a new drug application